An investigation of the molecular basis for the synergistic interaction of tirapazamine and cisplatin

International Journal of Radiation Oncology Biology Physics

Volumn 49, Issue 1, 2001, Pages 175-182

  Goldberg, Zelanna ^a   Evans, James ^a   Birrell, Geoffrey ^a   Brown, J Martin ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cisplatin; ERCC1; Tirapazamine; XPA

Indexed keywords

CELL PROTEIN; CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; MESSENGER RNA; PROTEIN XPA; TIRAPAZAMINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DNA CROSS LINKING; DNA REPAIR; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HYPOXIA; LUNG NON SMALL CELL CANCER; METABOLIC ACTIVATION; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; CELL HYPOXIA; CISPLATIN; DNA REPAIR; DNA-BINDING PROTEINS; DRUG SYNERGISM; ENDONUCLEASES; HUMANS; PROTEINS; RADIATION-SENSITIZING AGENTS; RNA, MESSENGER; TRIAZINES; TUMOR CELLS, CULTURED; UP-REGULATION; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

EID: 0035164690     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)01379-1     Document Type: Article

References (27)

1. Cisplatin, and tirapazamine in subjects with advanced previously untreated non-small-cell lung tumors. In; Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group
2. SR 4233 (tirapazamine). A new anticancer drug exploiting hypoxia in solid tumours
3. Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical
4. Hypoxia-specific cytotoxins in cancer therapy
5. Cytotoxicity, and DNA lesions produced by mitomycin C, and porfiromycin in hypoxic, and aerobic EMT6, and Chinese hamster ovary cells
6. Modification of the cytotoxic activity of mitomycin C by oxygen, and ascorbic acid in Chinese hamster ovary cells and a repair-deficient mutant
7. Cisplatin- and carboplatin-DNA adducts; Is PT-AG the cytotoxic lesion?
8. Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells
9. Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines
10. Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity
11. Cisplatin
12. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy
13. ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients
14. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy
15. Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells
16. Cisplatin and phorbol ester independently induce ERCC-1 protein in human ovarian carcinoma cells
17. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours
18. Expression of genes of potential importance in the response to chemotherapy and DNA repair in patients with ovarian cancer
19. Expression of genes involved in nucleotide excision repair, and sensitivity to cisplatin, and melphalan in human cancer cell lines
20. Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*)
21. Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin
22. Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine
23. Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents
24. Intranuclear metabolism of tirapazamine by matrix-associated reductases
25. The organization of replication, and transcription